<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60687-230-65
</NDCCode>
<PackageDescription>
50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-230-65) > 1 CAPSULE in 1 BLISTER PACK (60687-230-11)
</PackageDescription>
<NDC11Code>
60687-0230-65
</NDC11Code>
<ProductNDC>
60687-230
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Zonisamide
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Zonisamide
</NonProprietaryName>
<DosageFormName>
CAPSULE
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20161115
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA077869
</ApplicationNumber>
<LabelerName>
American Health Packaging
</LabelerName>
<SubstanceName>
ZONISAMIDE
</SubstanceName>
<StrengthNumber>
100
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Decreased Central Nervous System Disorganized Electrical Activity [PE],Anti-epileptic Agent [EPC],Sulfonamides [CS],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2020-02-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20211231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20161115
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20200131
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>